STK11 and non-small cell lung carcinoma: However, the lack of significant decrease in patient’s overall survival (OS) may be due to the extremely short OS of stage IV NSCLC in Calles’ study and to the selection of LKB1-mutated, rather than IHC-negative, tumors in our series.